Literature DB >> 21050236

The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study.

K M Fleming1, G P Aithal, T R Card, J West.   

Abstract

BACKGROUND: We lack population-based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. AIM: To determine the rate of decompensation and clinical progression of disease in patients with cirrhosis based upon clinical symptoms recorded electronically in general practice data.
METHODS: Using Cox proportional hazards regression, we modelled the rate of decompensation for patients from the UK General Practice Research Database with a diagnosis of cirrhosis between 1987 and 2002. We determined the clinical progression in the first year following diagnosis and subsequently categorizing patients through time according to a simple clinical staging system agreed at the Baveno IV consensus conference.
RESULTS: The rate of decompensation in patients with compensated cirrhosis was found to be 11% overall. The rate of decompensation was higher in the first year (at 31% compared with 7.3% afterwards) and in patients with an alcoholic aetiology. Patients with compensated cirrhosis had a 1-year probability of proceeding directly to death of 7% compared with 20% in patients with decompensated cirrhosis.
CONCLUSIONS: Using data recorded in general practice records, it is possible to determine the rate of decompensation and the clinical progression of disease in people with cirrhosis.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21050236     DOI: 10.1111/j.1365-2036.2010.04473.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  37 in total

1.  Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Authors:  Baoxian Liu; Mengchao Wei; Furong Liu; Shuling Chen; Zhenwei Peng; Bin Li; Qian Zhou; Haibo Wang; Sui Peng; Ming Kuang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

Review 3.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 4.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

Review 5.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

6.  Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.

Authors:  Vincent Lo Re; Joseph K Lim; Matthew Bidwell Goetz; Janet Tate; Harini Bathulapalli; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Farah Kidwai; Cynthia Brandt; Zachariah Dorey-Stein; K Rajender Reddy; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-05-27       Impact factor: 2.890

Review 7.  Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging.

Authors:  Ilona A Dekkers; Hildo J Lamb
Journal:  Br J Radiol       Date:  2018-07-23       Impact factor: 3.039

8.  Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines.

Authors:  Vikrant Rachakonda; Charles Gabbert; Amit Raina; Huanan Li; Shahid Malik; James P DeLany; Jaideep Behari
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

9.  Role of magnetic resonance elastography in compensated and decompensated liver disease.

Authors:  Sumeet K Asrani; Jayant A Talwalkar; Patrick S Kamath; Vijay H Shah; Giovanna Saracino; Linda Jennings; John B Gross; Sudhakar Venkatesh; Richard L Ehman
Journal:  J Hepatol       Date:  2013-12-19       Impact factor: 25.083

Review 10.  Clinical relevance of sarcopenia in patients with cirrhosis.

Authors:  Aldo J Montano-Loza
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.